Transmembrane TNF-alpha promotes chemoresistance in breast cancer cells

An Autoinhibited Dimeric Form of BAX Regulates the BAX Activation Pathway

(2016) Thomas P. Garner et al.   MOLECULAR CELL

Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer

(2016) Qing Chen et al.   NATURE

NF-κB in cancer therapy

(2015) Feng Li et al.   ARCHIVES OF TOXICOLOGY

Transmembrane TNF-  preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy

(2015) X. Zhou et al.   BLOOD

Topoisomerase II and leukemia

(2014) MaryJean Pendleton et al.   Annals of the New York Academy of Sciences

Conformational Rearrangements in the Pro-apoptotic Protein, Bax, as It Inserts into Mitochondria

(2014) Robert F. Gahl et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting Transmembrane TNF-α Suppresses Breast Cancer Growth

(2013) Mingxia Yu et al.   CANCER RESEARCH

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study

(2013) Miguel Martín et al.   JOURNAL OF CLINICAL ONCOLOGY

A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

(2012) Swarnali Acharyya et al.   CELL

Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer

(2012) Albert S. Baldwin   IMMUNOLOGICAL REVIEWS

Activation of Nrf2 Is Required for Up-Regulation of the π Class of Glutathione S-Transferase in Rat Primary Hepatocytes with l-Methionine Starvation

(2012) Ai-Hsuan Lin et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

(2012) Nathalie A. Johnson et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

(2012) John R Mackey et al.   LANCET ONCOLOGY

Various modes of cell death induced by DNA damage

(2012) O Surova et al.   ONCOGENE

Treatment-Related Protein Biomarker Expression Differs between Primary and Recurrent Ovarian Carcinomas

(2011) D. A. Zajchowski et al.   MOLECULAR CANCER THERAPEUTICS

Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line

(2010) Huan Meng et al.   ACS Nano

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expression of TNF-α leader sequence renders MCF-7 tumor cells resistant to the cytotoxicity of soluble TNF-α

(2008) Dan Yan et al.   BREAST CANCER RESEARCH AND TREATMENT

Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma

(2008) Shailendra Verma et al.   CANCER TREATMENT REVIEWS

Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?

(2008) D. Daniel et al.   CURRENT CANCER DRUG TARGETS

Influence of reverse signaling via membrane TNF-α on cytotoxicity of NK92 cells

(2008) Mingxia Yu et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Transmembrane TNF-α mediates “forward” and “reverse” signaling, inducing cell death or survival via the NF-κB pathway in Raji Burkitt lymphoma cells

(2008) Hailong Zhang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

ABC multidrug transporters: structure, function and role in chemoresistance

(2007) Frances J Sharom   PHARMACOGENOMICS